Mindray to Acquire 75% Stake in DiaSys Diagnostic Systems for €115 Million
August 2, 2023 at 7:19:41 AM
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has agreed to acquire 75% equity interest in DiaSys Diagnostic Systems GmbH from Gorka Holding GmbH, through Mindray Medical Netherlands B.V., for a preliminary cash consideration of approximately €115 million. The final purchase price will be determined as of closing. Upon completion of the proposed transaction, Mindray will hold 75% equity interest in DiaSys and consolidate DiaSys and its subsidiaries. Upon closing, Mindray Netherlands and Gorka Holding GmbH will proportionally contribute €40 million to DiaSys to support its future business development.
Founded in 1991 and headquartered in Holzheim, Germany, DiaSys is a globally recognized brand with over three decades of expertise in the fields of in vitro diagnostics. DiaSys has production facilities in Europe, APAC, and Latin America.
Going forward, Mindray will leverage DiaSys’ global supply platforms and international team of professionals to expedite overseas supply chain construction, in order to achieve the further expansion into medium to large volume customer segments worldwide, and offer more timely and comprehensive professional service to clients. At the same time, DiaSys’ extensive experience in clinical chemistry is also expected to bring synergies to Mindray’s IVD business. DiaSys’s ability to develop and produce IVD controls and calibrators will complement Mindray’s IVD product offering and enhance its system performance.
Closing of the proposed transaction is subject to customary regulatory approval as well as satisfaction of certain conditions agreed by the parties.
- G-MedTech -
About Collabrium Partners
Collabrium Partners is a Chinese leading independent investment banking firm focused on providing financial advisories on mergers & acquisitions, strategic planning, restructuring, private placement, independent opinions to corporations, financial institutions, public service agencies, and others.
For more information, please visit www.collabrium.com